-
公开(公告)号：US20100135982A1
公开(公告)日：2010-06-03
申请号：US12699129
申请日：2010-02-03
IPC分类号： A61K38/47 , A61K31/695 , A61K33/24 , A61P1/00
摘要： The present invention provides a composition for forming a compressed solid dosage form that is a free-flowing compressible admixture of simethicone, an adsorbant, and an optional active agent, wherein the weight ratio of simethicone to adsorbent is at least 1:2.22. Also included are solid dosage forms made from a free-flowing compressible admixture of simethicone, an adsorbant, and an optional active agent, wherein the weight ratio of simethicone to adsorbent is at least 1:2.22.
摘要翻译： 本发明提供一种用于形成压缩固体剂型的组合物，其是可与二甲基硅油，吸附剂和任选活性剂的自由流动的可压缩混合物，其中二甲硅油与吸附剂的重量比至少为1:2.22。 还包括由二甲硅油，吸附剂和任选的活性剂的自由流动的可压缩混合物制备的固体剂型，其中二甲硅油与吸附剂的重量比至少为1:2.22。
-
公开(公告)号：US07691409B2
公开(公告)日：2010-04-06
申请号：US11460741
申请日：2006-07-28
IPC分类号： A61K31/12 , A61K33/12 , A61K31/15 , A61K31/165 , A61K31/445
摘要： The present invention provides a composition for forming a compressed solid dosage form that is a free-flowing compressible admixture of simethicone, an adsorbant, and an optional active agent, wherein the weight ratio of simethicone to adsorbent is at least 1:2.22. Also included are solid dosage forms made from a free-flowing compressible admixture of simethicone, an adsorbant, and an optional active agent, wherein the weight ratio of simethicone to adsorbent is at least 1:2.22.
摘要翻译： 本发明提供一种用于形成压缩固体剂型的组合物，其是可与二甲基硅油，吸附剂和任选活性剂的自由流动的可压缩混合物，其中二甲硅油与吸附剂的重量比至少为1:2.22。 还包括由二甲硅油，吸附剂和任选的活性剂的自由流动的可压缩混合物制备的固体剂型，其中二甲硅油与吸附剂的重量比至少为1:2.22。
-
公开(公告)号：US07681238B2
公开(公告)日：2010-03-16
申请号：US11201531
申请日：2005-08-11
申请人： Daniel Plastina , Eduardo P. Oliveira , James H. Dooley, IV , James T. Walter , Jason S. Flaks , Sanjay Bhatt , William F. Schiefelbein
发明人： Daniel Plastina , Eduardo P. Oliveira , James H. Dooley, IV , James T. Walter , Jason S. Flaks , Sanjay Bhatt , William F. Schiefelbein
IPC分类号： G06F7/04
CPC分类号： H04N7/173 , G06F17/30017 , G06F21/10 , H04L63/0435 , H04N21/25875 , H04N21/4143 , H04N21/4788 , H04N21/6408 , H04N21/835 , H04N21/8355
摘要： A source device permits a user of a remote device to access a protected file on the source device when the user of the remote device has a right to access the protected file. The user locates the protected file on the source device using the remote device and accesses the protected file using a media player on the remote device. The media player constructs a path by which the source device streams the protected file. The remote device responds to an authentication request from the source device that the user of the remote device has a right to access the protected file. The user is authenticated to confirm that the user of the remote device has a right to access the protected file. The protected file is streamed to the remote device via a path constructed by the remote device.
摘要翻译： 当远程设备的用户有权访问受保护的文件时，源设备允许远程设备的用户访问源设备上的受保护文件。 用户使用远程设备定位源设备上的受保护文件，并使用远程设备上的媒体播放器访问受保护的文件。 媒体播放器构建源设备流保护文件的路径。 远程设备响应来自源设备的认证请求，远程设备的用户有权访问受保护的文件。 验证用户以确认远程设备的用户有权访问受保护的文件。 受保护的文件通过由远程设备构建的路径流传输到远程设备。
-
公开(公告)号：US06955903B2
公开(公告)日：2005-10-18
申请号：US10001733
申请日：2001-11-02
CPC分类号： A61K9/146 , A61K9/2054 , A61K38/47
摘要： A preblend for making lactase tablets is prepared containing about 1-99% (preferably about 200-60%) by weight lactase and about 1-99% (preferably about 40-80%) by weight microcrystalline cellulose. Lactase used in the preblend may be in combination with up to about 4 parts (preferably about 0.5-2 parts) by weight cutting agent such as sugars, starches, cellulose, and inorganic salts for each part by weight lactase. About 0.5-4% by weight lubricant such as magnesium stearate may be present in the preblend. A preferred preblend contains about 9.6 weight percent lactase and about 90 weight percent microcrystalline cellulose, or about 2000 to about 9000 FCC lactase units and from about 40 to about 80 weight percent microcrystalline cellulose. Another preferred preblend contains about 9.6 weight percent lactase, about 30.0 weight percent microcrystalline cellulose and about 59.4 weight percent mannitol. Each preblend may also contain magnesium stearate. A preferred lactase is from Aspergillus oryzae and the microcrystalline cellulose preferably has an average particle size of about 10-200 μm.
摘要翻译： 制备用于制备乳糖酶片剂的预混物，其含有约1-99重量％（优选约200-60重量％）乳糖酶和约1-99重量％（优选约40-80重量％）微晶纤维素。 在预混物中使用的乳酸酶可以与每份重量份乳糖酶最多约4份（优选约0.5-2份）重量的切割剂如糖，淀粉，纤维素和无机盐组合。 在预混物中可以存在约0.5-4重量％的润滑剂如硬脂酸镁。 优选的预混物包含约9.6重量％的乳糖酶和约90重量％的微晶纤维素，或约2000至约9000个FCC乳糖酶单元和约40至约80重量％的微晶纤维素。 另一种优选的预混物包含约9.6重量％的乳糖酶，约30.0重量％的微晶纤维素和约59.4重量％的甘露糖醇。 每种预混物也可以含有硬脂酸镁。 优选的乳糖酶来自米曲霉，微晶纤维素的平均粒径优选为约10-200μm。
-
公开(公告)号：US06660313B2
公开(公告)日：2003-12-09
申请号：US10067078
申请日：2002-02-04
IPC分类号： A23L128
CPC分类号： C12Y302/01108 , A23L29/06 , A23P10/28 , A23V2002/00 , A61K9/2018 , A61K9/2054 , A61K38/47 , A23V2250/6418 , A23V2250/51084
摘要： There is a formulation having improved chemical stability comprising: a) from about 1% to about 20% by weight of a combination of lactase and cutting agent where said combination has from 0 to about 4 parts by weight cutting agent for each part by weight lactase; b) from about 1% to about 98% by weight of microcrystalline cellulose; c) from about 0% to about 97% by weight of mannitol; and d) an effective amount of lubricant to aid compression.
摘要翻译： 具有改进的化学稳定性的制剂，其包含：a）约1重量％至约20重量％的乳糖酶和切割剂的组合，其中所述组合具有0至约4重量份的切割剂，用于每重量份乳糖酶 ; b）约1％至约98％重量的微晶纤维素; c）约0％至约97％重量的甘露糖醇; andd）有效量的润滑剂以辅助压缩。
-
公开(公告)号：US06365208B1
公开(公告)日：2002-04-02
申请号：US08943827
申请日：1997-10-03
IPC分类号： A23L128
CPC分类号： C12Y302/01108 , A23L29/06 , A23P10/28 , A23V2002/00 , A61K9/2018 , A61K9/2054 , A61K38/47 , A23V2250/6418 , A23V2250/51084
摘要： There is a formulation having improved chemical stability containing: a) from about 1% to about 20% by weight of a combination of lactase and cutting agent where said combination has from 0 to about 4 parts by weight cutting agent for each part by weight lactase; b) from about 1% to about 98% by weight of microcrystalline cellulose; c) from about 0% to about 97% by weight of mannitol; and d) an effective amount of lubricant to aid compression.
摘要翻译： 具有改进的化学稳定性的制剂，其含有：a）约1％至约20％重量的乳糖酶和切割剂的组合，其中所述组合具有0至约4重量份的切割剂，用于每重量份乳糖酶 ; b）约1％至约98％重量的微晶纤维素; c）约0％至约97％重量的甘露糖醇; andd）有效量的润滑剂以辅助压缩。
-
公开(公告)号：US06057139A
公开(公告)日：2000-05-02
申请号：US496824
申请日：1995-06-29
CPC分类号： A61K9/146 , A61K38/47 , A61K9/2054
摘要： A preblend for making lactase tablets is prepared containing about 1-99% (preferably about 20-60%) by weight lactase and about 1-99% (preferably about 40-80%) by weight microcrystalline cellulose. Lactase used in the preblend may be in combination with up to about 4 parts (preferably about 0.5-2 parts) by weight cutting agent such as sugars, starches, cellulose, and inorganic salts for each part by weight lactase. About 0.5-4% by weight lubricant such as magnesium stearate may be present in the preblend. A preferred preblend contains about 9.6 weight percent lactase and about 90 weight percent microcrystalline cellulose. Another preferred preblend contains about 9.6 weight percent lactase, about 30.0 weight percent microcrystalline cellulose and about 59.4 weight percent mannitol. Each preblend may also contain magnesium stearate. A preferred lactase is from Aspergillus oryzae and the microcrystalline cellulose preferably has an average particle size of about 20-200 .mu.m.
摘要翻译： 制备用于制备乳糖酶片剂的预混物，其含有约1-99重量％（优选约20-60重量％）乳糖酶和约1-99重量％（优选约40-80重量％）微晶纤维素。 在预混物中使用的乳酸酶可以与每份重量份乳糖酶最多约4份（优选约0.5-2份）重量的切割剂如糖，淀粉，纤维素和无机盐组合。 在预混物中可以存在约0.5-4重量％的润滑剂如硬脂酸镁。 优选的预混物含有约9.6重量％的乳糖酶和约90重量％的微晶纤维素。 另一种优选的预混物包含约9.6重量％的乳糖酶，约30.0重量％的微晶纤维素和约59.4重量％的甘露糖醇。 每种预混物也可以含有硬脂酸镁。 优选的乳糖酶来自米曲霉，微晶纤维素的平均粒径优选为约20-200μm。
-
公开(公告)号：US08635658B2
公开(公告)日：2014-01-21
申请号：US12463518
申请日：2009-05-11
申请人： Michael J. Patten , James T. Walter
发明人： Michael J. Patten , James T. Walter
CPC分类号： H04N5/44591 , G06F17/3082 , G06F17/3084 , H04N7/17318 , H04N21/23109 , H04N21/2383 , H04N21/26283 , H04N21/4113 , H04N21/414 , H04N21/4143 , H04N21/4333 , H04N21/4334 , H04N21/436 , H04N21/4382 , H04N21/4532 , H04N21/4622 , H04N21/47214 , H04N21/4782 , H04N21/4828 , H04N21/8133
摘要： Methods for providing access to third-party content related to a television program of interest to a user via a single user interface. When a user schedules a recording of a television program, the metadata associated with the television program is obtained. At least one broadcast network content provider and at least one non-broadcast network content provider are queried for content relevant to the metadata. Content received from the at least one broadcast network content provider and the at least one non-broadcast network content provider is aggregated by type of media and stored. A navigation strip is rendered providing access to the recorded television program and the content received from the at least one broadcast network content provider and the at least one non-broadcast network content provider.
摘要翻译： 用于经由单个用户界面向用户提供与感兴趣的电视节目相关的第三方内容的访问的方法。 当用户安排电视节目的记录时，获得与电视节目相关联的元数据。 针对与元数据相关的内容，查询至少一个广播网络内容提供商和至少一个非广播网络内容提供商。 从至少一个广播网络内容提供商接收的内容和至少一个非广播网络内容提供商通过媒体的类型进行聚合并存储。 提供导航条提供对所记录的电视节目的访问和从至少一个广播网络内容提供商和至少一个非广播网络内容提供商接收的内容。
-
公开(公告)号：US08562633B2
公开(公告)日：2013-10-22
申请号：US10910501
申请日：2004-08-02
IPC分类号： A61B17/08
CPC分类号： A61F2/0063 , A61B17/00234 , A61B2017/00004 , A61F2250/0031 , A61L27/48 , A61L27/58 , C08L27/18
摘要： The present invention is a composite medical device having a non-bioabsorbable implantable tissue repair or reconstruction component and a resilient bioabsorbable support member component that aids in deployment and placement of the implantable component at a surgical site. Following deployment, the support member component is readily bioabsorbed and removed from the implantable component. The invention is particularly useful in laproscopic, endoluminal, and other surgical procedures.
摘要翻译： 本发明是一种复合医疗装置，其具有非生物可吸收的可植入组织修复或重建组件和有助于将可植入组件部署和放置在外科手术部位的弹性生物可吸收性支撑构件部件。 在部署之后，支撑构件部件容易地从可植入部件生物吸收和移除。 本发明在腹腔镜，腔内和其他外科手术中特别有用。
-
公开(公告)号：US20080092211A1
公开(公告)日：2008-04-17
申请号：US11549459
申请日：2006-10-13
CPC分类号： H04L9/3271 , H04L9/3213 , H04L9/3247 , H04L9/3263 , H04L63/04 , H04L63/0823 , H04L63/126 , H04L2209/603 , H04L2209/80
摘要： A secure handshake service is implemented among a plurality of UPnP (Universal Plug and Play) portable media devices and endpoints in an open network hosting one or more UPnP services. A first portable media device receives a first request for a hosted service from a second portable media device via the network. The first portable media device authenticates authorizes the second portable media device as a function of the certificate of the request. The second portable media device is allowed to access the requested service hosted on the first portable media device if the second portable media device has been authenticated and authorized by the first portable media device.
摘要翻译： 在多个UPnP（通用即插即用）便携式媒体设备和承载一个或多个UPnP服务的开放网络中的端点之间实现安全握手服务。 第一便携式媒体设备经由网络从第二便携式媒体设备接收对托管服务的第一请求。 第一便携式媒体设备认证授权第二便携式媒体设备作为该请求的证书的功能。 如果第二便携式媒体设备已被第一便携式媒体设备认证和授权，则第二便携式媒体设备被允许访问托管在第一便携式媒体设备上的所请求的服务。
-
-
-
-
-
-
-
-
-
搜索结果
16 条记录 (耗时 0.023 秒)
